Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Nucleic Acid Isolation and Purification Market by Product (Reagents, Kits, Instruments), by Type (Messenger RNA Isolation and Purification, Plasmid DNA Isolation and Purification, Circulating Nucleic Acid Isolation and Purification, Genomic DNA Isolation and Purification, PCR Cleanup, Others), by Method (Magnetic Bead-based Isolation and Purification, Column-based Isolation and Purification, Reagent-based Isolation and Purification, Others), by Application (Personalized Medicine, Drug Discovery Development, Others) and by End User (Academic Government Research Institutes, Pharmaceutical Biotechnology Companies, Hospitals Diagnostic Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

A11221

Pages: NA

Charts: NA

Tables: NA

Nucleic acid sample preparation involves a range of techniques to transform a sample, which cannot be directly analyzed into one that fits the requirements of the analytical technique to be used, such as reverse transcription (RT) or PCR. Nucleic acid sample purification and quality assessment are important steps in experimental workflows since the quality of nucleic acids will affect the performance in downstream reactions. When working with cells or tissues as the starting material, the first step of the nucleic acid purification process is cell lysis or membrane permeabilization. This process breaks open the cell membranes and disrupts the cellular structure to create a cell lysate. This allows the nucleic acid of interest to be accessed and separated away from unwanted cellular components

COVID-19 scenario analysis:

The main healthcare industries such as Pharmaceutical and biotech companies joined their hands with governments around the globe and are working to manage the COVID-19 outbreak. This is done by supporting the development of vaccines to planning for medicines supply chain challenges. There is continuous research going on regarding the development of vaccines for the management of the disease. There are around 115 vaccine candidates and 155 molecules are in the R&D pipeline. The commonly used drugs such as Hydroxychloroquine have seen dramatic surge in demand for the management of COVID-19. This high demand for these drugs has presented bigger opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. The demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is anticipated to witness a significant growth in the coming years.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The major factor affecting the Nucleic Acid Isolation and Purification market includes the increase in the technological advancements for the isolation and purification of nucleic acid, would help the market grow in the forecast period. Furthermore, the rise in R&D for the extraction of nucleic acid would propel the industry to grow. The surge in the automation of the procedure would boost the industry in the near future. However, the higher cost of the automated system may impede the market growth.

New product advancements to flourish the market

In June 2020, Omega Bio-tek, Inc. announced the launch of the Mag-Bind Viral RNA Xpress Kit for the rapid and reliable isolation of Viral RNA from nasopharyngeal (NP) swab specimens that are dry or in viral transport media (VTM). The new kit aims to combat the shortage of RNA purification kits, which is used in the first steps of COVID-19 testing. The new magnetic bead-based extraction kit is adaptable to most liquid handling platforms for scalable, high-throughput purification.

In January 2018, Beckman Coulter Life Sciences launched a family of FormaPure reagent kits for extracting nucleic acid from often challenging formalin-fixed, paraffin-embedded (FFPE) tissues. FormaPure reagent kits represent a single chemistry system designed and optimized for use in next-generation sequencing (NGS) and other downstream applications, including qPCR/ddPCR/PCR.

Surge in mergers and acquisitions to boost the market

In January 2017, Takara Bio USA Holdings, Inc. ("TBUSH") announced that it has completed the acquisition of Rubicon Genomics, Inc. ("Rubicon"). The Takara Bio Group provides a wide range of life science products and services under the Takara, Clontech, and Cellartis brands that assist discovery, translational and clinical scientists in the advancement of their work.

The Rubicon acquisition will allow the Takara Bio Group to augment and expand its worldwide commercial offerings in next generation sequencing (NGS) sample preparation and expand into new Nucleic Acid Isolation and Purification market. The acquisition will helps in gaining maximum attention of the healthcare professionals and hence would boost the growth in the near future.

Key benefits of the report:

  • This study presents the analytical depiction of the global Nucleic Acid Isolation and Purification industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Nucleic Acid Isolation and Purification market share.
  • The current market is quantitatively analyzed to highlight the global Nucleic Acid Isolation and Purification market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the Nucleic Acid Isolation and Purification market.
  • The report provides a detailed global market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Nucleic Acid Isolation and Purification Market research report:

  • Who are the leading market players active in the Nucleic Acid Isolation and Purification market?
  • What are the current trends will influence the Nucleic Acid Isolation and Purification market in the next few years?
  • What are the driving factors, restraints, and opportunities in the Nucleic Acid Isolation and Purification market?
  • What are the projections for the future that would help in tasking further strategic steps?

Key Market Segments

  • By Product
    • Reagents
    • Kits
    • Instruments
  • By Type
    • Messenger RNA Isolation and Purification
    • Plasmid DNA Isolation and Purification
    • Circulating Nucleic Acid Isolation and Purification
    • Genomic DNA Isolation and Purification
    • PCR Cleanup
    • Others
  • By Method
    • Magnetic Bead-based Isolation and Purification
    • Column-based Isolation and Purification
    • Reagent-based Isolation and Purification
    • Others
  • By Application
    • Personalized Medicine
    • Drug Discovery & Development
    • Others
  • By End User
    • Academic & Government Research Institutes
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Diagnostic Centers
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • Japna
      • China
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA


Key Market Players

  • Roche AG
  • GE Healthcare
  • Merck KGaA
  • Takara Bio, Inc
  • Promega Corporation
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Danaher Corporation
  • QIAGEN N.V


Other Players

  • New England Biolabs
  • Bio-Rad Laboratories
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Reagents

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Kits

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Instruments

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Type

    • 5.2. Messenger RNA Isolation And Purification

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Plasmid DNA Isolation And Purification

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Circulating Nucleic Acid Isolation And Purification

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Genomic DNA Isolation And Purification

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. PCR Cleanup

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Others

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

  • CHAPTER 6: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Method

    • 6.2. Magnetic Bead-based Isolation And Purification

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Column-based Isolation And Purification

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Reagent-based Isolation And Purification

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Application

    • 7.2. Personalized Medicine

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Drug Discovery And Development

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Others

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By End User

    • 8.2. Academic And Government Research Institutes

      • 8.2.1. Key Market Trends, Growth Factors and Opportunities

      • 8.2.2. Market Size and Forecast, By Region

      • 8.2.3. Market Share Analysis, By Country

    • 8.3. Pharmaceutical And Biotechnology Companies

      • 8.3.1. Key Market Trends, Growth Factors and Opportunities

      • 8.3.2. Market Size and Forecast, By Region

      • 8.3.3. Market Share Analysis, By Country

    • 8.4. Hospitals And Diagnostic Centers

      • 8.4.1. Key Market Trends, Growth Factors and Opportunities

      • 8.4.2. Market Size and Forecast, By Region

      • 8.4.3. Market Share Analysis, By Country

    • 8.5. Others

      • 8.5.1. Key Market Trends, Growth Factors and Opportunities

      • 8.5.2. Market Size and Forecast, By Region

      • 8.5.3. Market Share Analysis, By Country

  • CHAPTER 9: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION

    • 9.1. Market Overview

      • 9.1.1 Market Size and Forecast, By Region

    • 9.2. North America

      • 9.2.1. Key Market Trends and Opportunities

      • 9.2.2. Market Size and Forecast, By Product

      • 9.2.3. Market Size and Forecast, By Type

      • 9.2.4. Market Size and Forecast, By Method

      • 9.2.5. Market Size and Forecast, By Application

      • 9.2.6. Market Size and Forecast, By End User

      • 9.2.7. Market Size and Forecast, By Country

      • 9.2.8. U.S. Nucleic Acid Isolation And Purification Market

        • 9.2.8.1. Market Size and Forecast, By Product
        • 9.2.8.2. Market Size and Forecast, By Type
        • 9.2.8.3. Market Size and Forecast, By Method
        • 9.2.8.4. Market Size and Forecast, By Application
        • 9.2.8.5. Market Size and Forecast, By End User
      • 9.2.9. Canada Nucleic Acid Isolation And Purification Market

        • 9.2.9.1. Market Size and Forecast, By Product
        • 9.2.9.2. Market Size and Forecast, By Type
        • 9.2.9.3. Market Size and Forecast, By Method
        • 9.2.9.4. Market Size and Forecast, By Application
        • 9.2.9.5. Market Size and Forecast, By End User
      • 9.2.10. Mexico Nucleic Acid Isolation And Purification Market

        • 9.2.10.1. Market Size and Forecast, By Product
        • 9.2.10.2. Market Size and Forecast, By Type
        • 9.2.10.3. Market Size and Forecast, By Method
        • 9.2.10.4. Market Size and Forecast, By Application
        • 9.2.10.5. Market Size and Forecast, By End User
    • 9.3. Europe

      • 9.3.1. Key Market Trends and Opportunities

      • 9.3.2. Market Size and Forecast, By Product

      • 9.3.3. Market Size and Forecast, By Type

      • 9.3.4. Market Size and Forecast, By Method

      • 9.3.5. Market Size and Forecast, By Application

      • 9.3.6. Market Size and Forecast, By End User

      • 9.3.7. Market Size and Forecast, By Country

      • 9.3.8. France Nucleic Acid Isolation And Purification Market

        • 9.3.8.1. Market Size and Forecast, By Product
        • 9.3.8.2. Market Size and Forecast, By Type
        • 9.3.8.3. Market Size and Forecast, By Method
        • 9.3.8.4. Market Size and Forecast, By Application
        • 9.3.8.5. Market Size and Forecast, By End User
      • 9.3.9. Germany Nucleic Acid Isolation And Purification Market

        • 9.3.9.1. Market Size and Forecast, By Product
        • 9.3.9.2. Market Size and Forecast, By Type
        • 9.3.9.3. Market Size and Forecast, By Method
        • 9.3.9.4. Market Size and Forecast, By Application
        • 9.3.9.5. Market Size and Forecast, By End User
      • 9.3.10. Italy Nucleic Acid Isolation And Purification Market

        • 9.3.10.1. Market Size and Forecast, By Product
        • 9.3.10.2. Market Size and Forecast, By Type
        • 9.3.10.3. Market Size and Forecast, By Method
        • 9.3.10.4. Market Size and Forecast, By Application
        • 9.3.10.5. Market Size and Forecast, By End User
      • 9.3.11. Spain Nucleic Acid Isolation And Purification Market

        • 9.3.11.1. Market Size and Forecast, By Product
        • 9.3.11.2. Market Size and Forecast, By Type
        • 9.3.11.3. Market Size and Forecast, By Method
        • 9.3.11.4. Market Size and Forecast, By Application
        • 9.3.11.5. Market Size and Forecast, By End User
      • 9.3.12. UK Nucleic Acid Isolation And Purification Market

        • 9.3.12.1. Market Size and Forecast, By Product
        • 9.3.12.2. Market Size and Forecast, By Type
        • 9.3.12.3. Market Size and Forecast, By Method
        • 9.3.12.4. Market Size and Forecast, By Application
        • 9.3.12.5. Market Size and Forecast, By End User
      • 9.3.13. Russia Nucleic Acid Isolation And Purification Market

        • 9.3.13.1. Market Size and Forecast, By Product
        • 9.3.13.2. Market Size and Forecast, By Type
        • 9.3.13.3. Market Size and Forecast, By Method
        • 9.3.13.4. Market Size and Forecast, By Application
        • 9.3.13.5. Market Size and Forecast, By End User
      • 9.3.14. Rest Of Europe Nucleic Acid Isolation And Purification Market

        • 9.3.14.1. Market Size and Forecast, By Product
        • 9.3.14.2. Market Size and Forecast, By Type
        • 9.3.14.3. Market Size and Forecast, By Method
        • 9.3.14.4. Market Size and Forecast, By Application
        • 9.3.14.5. Market Size and Forecast, By End User
    • 9.4. Asia-Pacific

      • 9.4.1. Key Market Trends and Opportunities

      • 9.4.2. Market Size and Forecast, By Product

      • 9.4.3. Market Size and Forecast, By Type

      • 9.4.4. Market Size and Forecast, By Method

      • 9.4.5. Market Size and Forecast, By Application

      • 9.4.6. Market Size and Forecast, By End User

      • 9.4.7. Market Size and Forecast, By Country

      • 9.4.8. China Nucleic Acid Isolation And Purification Market

        • 9.4.8.1. Market Size and Forecast, By Product
        • 9.4.8.2. Market Size and Forecast, By Type
        • 9.4.8.3. Market Size and Forecast, By Method
        • 9.4.8.4. Market Size and Forecast, By Application
        • 9.4.8.5. Market Size and Forecast, By End User
      • 9.4.9. Japan Nucleic Acid Isolation And Purification Market

        • 9.4.9.1. Market Size and Forecast, By Product
        • 9.4.9.2. Market Size and Forecast, By Type
        • 9.4.9.3. Market Size and Forecast, By Method
        • 9.4.9.4. Market Size and Forecast, By Application
        • 9.4.9.5. Market Size and Forecast, By End User
      • 9.4.10. India Nucleic Acid Isolation And Purification Market

        • 9.4.10.1. Market Size and Forecast, By Product
        • 9.4.10.2. Market Size and Forecast, By Type
        • 9.4.10.3. Market Size and Forecast, By Method
        • 9.4.10.4. Market Size and Forecast, By Application
        • 9.4.10.5. Market Size and Forecast, By End User
      • 9.4.11. South Korea Nucleic Acid Isolation And Purification Market

        • 9.4.11.1. Market Size and Forecast, By Product
        • 9.4.11.2. Market Size and Forecast, By Type
        • 9.4.11.3. Market Size and Forecast, By Method
        • 9.4.11.4. Market Size and Forecast, By Application
        • 9.4.11.5. Market Size and Forecast, By End User
      • 9.4.12. Australia Nucleic Acid Isolation And Purification Market

        • 9.4.12.1. Market Size and Forecast, By Product
        • 9.4.12.2. Market Size and Forecast, By Type
        • 9.4.12.3. Market Size and Forecast, By Method
        • 9.4.12.4. Market Size and Forecast, By Application
        • 9.4.12.5. Market Size and Forecast, By End User
      • 9.4.13. Thailand Nucleic Acid Isolation And Purification Market

        • 9.4.13.1. Market Size and Forecast, By Product
        • 9.4.13.2. Market Size and Forecast, By Type
        • 9.4.13.3. Market Size and Forecast, By Method
        • 9.4.13.4. Market Size and Forecast, By Application
        • 9.4.13.5. Market Size and Forecast, By End User
      • 9.4.14. Malaysia Nucleic Acid Isolation And Purification Market

        • 9.4.14.1. Market Size and Forecast, By Product
        • 9.4.14.2. Market Size and Forecast, By Type
        • 9.4.14.3. Market Size and Forecast, By Method
        • 9.4.14.4. Market Size and Forecast, By Application
        • 9.4.14.5. Market Size and Forecast, By End User
      • 9.4.15. Indonesia Nucleic Acid Isolation And Purification Market

        • 9.4.15.1. Market Size and Forecast, By Product
        • 9.4.15.2. Market Size and Forecast, By Type
        • 9.4.15.3. Market Size and Forecast, By Method
        • 9.4.15.4. Market Size and Forecast, By Application
        • 9.4.15.5. Market Size and Forecast, By End User
      • 9.4.16. Rest of Asia Pacific Nucleic Acid Isolation And Purification Market

        • 9.4.16.1. Market Size and Forecast, By Product
        • 9.4.16.2. Market Size and Forecast, By Type
        • 9.4.16.3. Market Size and Forecast, By Method
        • 9.4.16.4. Market Size and Forecast, By Application
        • 9.4.16.5. Market Size and Forecast, By End User
    • 9.5. LAMEA

      • 9.5.1. Key Market Trends and Opportunities

      • 9.5.2. Market Size and Forecast, By Product

      • 9.5.3. Market Size and Forecast, By Type

      • 9.5.4. Market Size and Forecast, By Method

      • 9.5.5. Market Size and Forecast, By Application

      • 9.5.6. Market Size and Forecast, By End User

      • 9.5.7. Market Size and Forecast, By Country

      • 9.5.8. Brazil Nucleic Acid Isolation And Purification Market

        • 9.5.8.1. Market Size and Forecast, By Product
        • 9.5.8.2. Market Size and Forecast, By Type
        • 9.5.8.3. Market Size and Forecast, By Method
        • 9.5.8.4. Market Size and Forecast, By Application
        • 9.5.8.5. Market Size and Forecast, By End User
      • 9.5.9. South Africa Nucleic Acid Isolation And Purification Market

        • 9.5.9.1. Market Size and Forecast, By Product
        • 9.5.9.2. Market Size and Forecast, By Type
        • 9.5.9.3. Market Size and Forecast, By Method
        • 9.5.9.4. Market Size and Forecast, By Application
        • 9.5.9.5. Market Size and Forecast, By End User
      • 9.5.10. Saudi Arabia Nucleic Acid Isolation And Purification Market

        • 9.5.10.1. Market Size and Forecast, By Product
        • 9.5.10.2. Market Size and Forecast, By Type
        • 9.5.10.3. Market Size and Forecast, By Method
        • 9.5.10.4. Market Size and Forecast, By Application
        • 9.5.10.5. Market Size and Forecast, By End User
      • 9.5.11. UAE Nucleic Acid Isolation And Purification Market

        • 9.5.11.1. Market Size and Forecast, By Product
        • 9.5.11.2. Market Size and Forecast, By Type
        • 9.5.11.3. Market Size and Forecast, By Method
        • 9.5.11.4. Market Size and Forecast, By Application
        • 9.5.11.5. Market Size and Forecast, By End User
      • 9.5.12. Argentina Nucleic Acid Isolation And Purification Market

        • 9.5.12.1. Market Size and Forecast, By Product
        • 9.5.12.2. Market Size and Forecast, By Type
        • 9.5.12.3. Market Size and Forecast, By Method
        • 9.5.12.4. Market Size and Forecast, By Application
        • 9.5.12.5. Market Size and Forecast, By End User
      • 9.5.13. Rest of LAMEA Nucleic Acid Isolation And Purification Market

        • 9.5.13.1. Market Size and Forecast, By Product
        • 9.5.13.2. Market Size and Forecast, By Type
        • 9.5.13.3. Market Size and Forecast, By Method
        • 9.5.13.4. Market Size and Forecast, By Application
        • 9.5.13.5. Market Size and Forecast, By End User
  • CHAPTER 10: COMPETITIVE LANDSCAPE

    • 10.1. Introduction

    • 10.2. Top Winning Strategies

    • 10.3. Product Mapping Of Top 10 Player

    • 10.4. Competitive Dashboard

    • 10.5. Competitive Heatmap

    • 10.6. Top Player Positioning, 2024

  • CHAPTER 11: COMPANY PROFILES

    • 11.1. QIAGEN N.V

      • 11.1.1. Company Overview

      • 11.1.2. Key Executives

      • 11.1.3. Company Snapshot

      • 11.1.4. Operating Business Segments

      • 11.1.5. Product Portfolio

      • 11.1.6. Business Performance

      • 11.1.7. Key Strategic Moves and Developments

    • 11.2. Agilent Technologies Inc

      • 11.2.1. Company Overview

      • 11.2.2. Key Executives

      • 11.2.3. Company Snapshot

      • 11.2.4. Operating Business Segments

      • 11.2.5. Product Portfolio

      • 11.2.6. Business Performance

      • 11.2.7. Key Strategic Moves and Developments

    • 11.3. Thermo Fisher Scientific Inc.

      • 11.3.1. Company Overview

      • 11.3.2. Key Executives

      • 11.3.3. Company Snapshot

      • 11.3.4. Operating Business Segments

      • 11.3.5. Product Portfolio

      • 11.3.6. Business Performance

      • 11.3.7. Key Strategic Moves and Developments

    • 11.4. Roche AG

      • 11.4.1. Company Overview

      • 11.4.2. Key Executives

      • 11.4.3. Company Snapshot

      • 11.4.4. Operating Business Segments

      • 11.4.5. Product Portfolio

      • 11.4.6. Business Performance

      • 11.4.7. Key Strategic Moves and Developments

    • 11.5. Merck KGaA

      • 11.5.1. Company Overview

      • 11.5.2. Key Executives

      • 11.5.3. Company Snapshot

      • 11.5.4. Operating Business Segments

      • 11.5.5. Product Portfolio

      • 11.5.6. Business Performance

      • 11.5.7. Key Strategic Moves and Developments

    • 11.6. Illumina, Inc

      • 11.6.1. Company Overview

      • 11.6.2. Key Executives

      • 11.6.3. Company Snapshot

      • 11.6.4. Operating Business Segments

      • 11.6.5. Product Portfolio

      • 11.6.6. Business Performance

      • 11.6.7. Key Strategic Moves and Developments

    • 11.7. Takara Bio, Inc

      • 11.7.1. Company Overview

      • 11.7.2. Key Executives

      • 11.7.3. Company Snapshot

      • 11.7.4. Operating Business Segments

      • 11.7.5. Product Portfolio

      • 11.7.6. Business Performance

      • 11.7.7. Key Strategic Moves and Developments

    • 11.8. Promega Corporation

      • 11.8.1. Company Overview

      • 11.8.2. Key Executives

      • 11.8.3. Company Snapshot

      • 11.8.4. Operating Business Segments

      • 11.8.5. Product Portfolio

      • 11.8.6. Business Performance

      • 11.8.7. Key Strategic Moves and Developments

    • 11.9. GE Healthcare

      • 11.9.1. Company Overview

      • 11.9.2. Key Executives

      • 11.9.3. Company Snapshot

      • 11.9.4. Operating Business Segments

      • 11.9.5. Product Portfolio

      • 11.9.6. Business Performance

      • 11.9.7. Key Strategic Moves and Developments

    • 11.10. Danaher Corporation

      • 11.10.1. Company Overview

      • 11.10.2. Key Executives

      • 11.10.3. Company Snapshot

      • 11.10.4. Operating Business Segments

      • 11.10.5. Product Portfolio

      • 11.10.6. Business Performance

      • 11.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR REAGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR KITS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR INSTRUMENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MESSENGER RNA ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PLASMID DNA ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR GENOMIC DNA ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PCR CLEANUP, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR COLUMN-BASED ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR REAGENT-BASED ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 20. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 21. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 22. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 23. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 24. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 25. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 26. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 27. NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 28. NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 29. NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 30. NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 31. NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 32. NORTH AMERICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. U.S. NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. U.S. NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 35. U.S. NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 36. U.S. NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 37. U.S. NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. CANADA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 39. CANADA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 40. CANADA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 41. CANADA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 42. CANADA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 43. MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 44. MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 45. MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 46. MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. MEXICO NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 49. EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 50. EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 51. EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 52. EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 55. FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 56. FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 57. FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 58. FRANCE NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 61. GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 62. GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. GERMANY NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 64. ITALY NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 65. ITALY NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 66. ITALY NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 67. ITALY NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 68. ITALY NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 70. SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 71. SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 72. SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 73. SPAIN NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 74. UK NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 75. UK NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 76. UK NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 77. UK NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 78. UK NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 79. RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 80. RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 81. RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 82. RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 83. RUSSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 84. REST OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 85. REST OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 86. REST OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 87. REST OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 88. REST OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 89. ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 90. ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 91. ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 92. ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 93. ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 94. ASIA-PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 95. CHINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 96. CHINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 97. CHINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 98. CHINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 99. CHINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 100. JAPAN NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 101. JAPAN NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 102. JAPAN NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 103. JAPAN NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 104. JAPAN NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 105. INDIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 106. INDIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 107. INDIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 108. INDIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 109. INDIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 110. SOUTH KOREA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 111. SOUTH KOREA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 112. SOUTH KOREA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 113. SOUTH KOREA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 114. SOUTH KOREA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 115. AUSTRALIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 116. AUSTRALIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 117. AUSTRALIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 118. AUSTRALIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 119. AUSTRALIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 120. THAILAND NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 121. THAILAND NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 122. THAILAND NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 123. THAILAND NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 124. THAILAND NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 125. MALAYSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 126. MALAYSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 127. MALAYSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 128. MALAYSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 129. MALAYSIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 130. INDONESIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 131. INDONESIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 132. INDONESIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 133. INDONESIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 134. INDONESIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 135. REST OF ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 136. REST OF ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 137. REST OF ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 138. REST OF ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 139. REST OF ASIA PACIFIC NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 140. LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 141. LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 142. LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 143. LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 144. LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 145. LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 146. BRAZIL NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 147. BRAZIL NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 148. BRAZIL NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 149. BRAZIL NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 150. BRAZIL NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 151. SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 152. SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 153. SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 154. SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 155. SOUTH AFRICA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 156. SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 157. SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 158. SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 159. SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 160. SAUDI ARABIA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 161. UAE NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 162. UAE NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 163. UAE NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 164. UAE NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 165. UAE NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 166. ARGENTINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 167. ARGENTINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 168. ARGENTINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 169. ARGENTINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 170. ARGENTINA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 171. REST OF LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 172. REST OF LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY TYPE, 2025-2033 ($MILLION)
  • TABLE 173. REST OF LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY METHOD, 2025-2033 ($MILLION)
  • TABLE 174. REST OF LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 175. REST OF LAMEA NUCLEIC ACID ISOLATION AND PURIFICATION, BY END USER, 2025-2033 ($MILLION)
  • TABLE 176. QIAGEN N.V: KEY EXECUTIVES
  • TABLE 177. QIAGEN N.V: COMPANY SNAPSHOT
  • TABLE 178. QIAGEN N.V: OPERATING SEGMENTS
  • TABLE 179. QIAGEN N.V: PRODUCT PORTFOLIO
  • TABLE 180. QIAGEN N.V: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 181. AGILENT TECHNOLOGIES INC: KEY EXECUTIVES
  • TABLE 182. AGILENT TECHNOLOGIES INC: COMPANY SNAPSHOT
  • TABLE 183. AGILENT TECHNOLOGIES INC: OPERATING SEGMENTS
  • TABLE 184. AGILENT TECHNOLOGIES INC: PRODUCT PORTFOLIO
  • TABLE 185. AGILENT TECHNOLOGIES INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 186. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 187. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 188. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
  • TABLE 189. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 190. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 191. ROCHE AG: KEY EXECUTIVES
  • TABLE 192. ROCHE AG: COMPANY SNAPSHOT
  • TABLE 193. ROCHE AG: OPERATING SEGMENTS
  • TABLE 194. ROCHE AG: PRODUCT PORTFOLIO
  • TABLE 195. ROCHE AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 196. MERCK KGAA: KEY EXECUTIVES
  • TABLE 197. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 198. MERCK KGAA: OPERATING SEGMENTS
  • TABLE 199. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 200. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 201. ILLUMINA, INC: KEY EXECUTIVES
  • TABLE 202. ILLUMINA, INC: COMPANY SNAPSHOT
  • TABLE 203. ILLUMINA, INC: OPERATING SEGMENTS
  • TABLE 204. ILLUMINA, INC: PRODUCT PORTFOLIO
  • TABLE 205. ILLUMINA, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 206. TAKARA BIO, INC: KEY EXECUTIVES
  • TABLE 207. TAKARA BIO, INC: COMPANY SNAPSHOT
  • TABLE 208. TAKARA BIO, INC: OPERATING SEGMENTS
  • TABLE 209. TAKARA BIO, INC: PRODUCT PORTFOLIO
  • TABLE 210. TAKARA BIO, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 211. PROMEGA CORPORATION: KEY EXECUTIVES
  • TABLE 212. PROMEGA CORPORATION: COMPANY SNAPSHOT
  • TABLE 213. PROMEGA CORPORATION: OPERATING SEGMENTS
  • TABLE 214. PROMEGA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 215. PROMEGA CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 216. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 217. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 218. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 219. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 220. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 221. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 222. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 223. DANAHER CORPORATION: OPERATING SEGMENTS
  • TABLE 224. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 225. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 3. SEGMENTATION NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 11. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR REAGENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR KITS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR INSTRUMENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 16. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MESSENGER RNA ISOLATION AND PURIFICATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PLASMID DNA ISOLATION AND PURIFICATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR GENOMIC DNA ISOLATION AND PURIFICATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PCR CLEANUP, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 22. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SEGMENTATION, BY BY METHOD
  • FIGURE 23. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR COLUMN-BASED ISOLATION AND PURIFICATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR REAGENT-BASED ISOLATION AND PURIFICATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 28. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 29. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 30. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 31. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SEGMENTATION, BY BY END USER
  • FIGURE 32. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 33. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 34. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 35. NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 36. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 37. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 38. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 39. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 40. COMPETITIVE DASHBOARD
  • FIGURE 41. COMPETITIVE HEATMAP: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 42. TOP PLAYER POSITIONING, 2024
  • FIGURE 43. QIAGEN N.V: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. QIAGEN N.V: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. QIAGEN N.V: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. AGILENT TECHNOLOGIES INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. AGILENT TECHNOLOGIES INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. AGILENT TECHNOLOGIES INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. ROCHE AG: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. ROCHE AG: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. ROCHE AG: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. MERCK KGAA: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. MERCK KGAA: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. ILLUMINA, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. ILLUMINA, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. ILLUMINA, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 61. TAKARA BIO, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 62. TAKARA BIO, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 63. TAKARA BIO, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 64. PROMEGA CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 65. PROMEGA CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 66. PROMEGA CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 67. GE HEALTHCARE: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 68. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 69. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 70. DANAHER CORPORATION: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 71. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 72. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Nucleic Acid Isolation and Purification Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue